Blood markers to predict outcome in sepsis patients
Part of Infections clinical trials.
This study looks at simple blood tests (like levels of certain white blood cells and a protein called procalcitonin) to see if they can predict how well people with sepsis will do in the intensive care unit. It may help doctors understand your infection better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have sepsis (a severe infection that affects your whole body).
- You cannot be pregnant.
- You cannot have cancer, be on medications that suppress your immune system, or have a blood disorder.
- You cannot have major injuries, burns, severe liver cirrhosis (Child-Pugh Class C), or be on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood test measurements (neutrophil/lymphocyte ratio and lactate/albumin ratio) to see which better predicts how severe an infection is in ICU patients with sepsis. It aims to find a simpler way to track inflammation.
This trial tests whether a simple blood test (the capillary leak index) can help doctors better predict how sepsis will progress in people recovering from abdominal surgery. If you are in the ICU after surgery for an abdominal infection, this study may help guide your care.
This study looks at whether levels of certain substances in your blood (uric acid, albumin, and lactate) can predict how well you do when you have sepsis. It might help doctors better understand your condition and guide your care in the ICU.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This study looks at whether simple blood tests and a bedside score can help predict who is more likely to die from sepsis in the ICU. It does not involve any experimental drug or treatment—it just tracks existing lab results and outcomes.
This study looks at whether platelet counts (a type of blood cell that helps clotting) can predict how likely a patient is to survive sepsis. If you are hospitalized with sepsis, your platelet levels may be measured to see if they can help doctors know who needs more intensive care.
Hear when a new Platelets trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.